--Xerox Shares Slump Premarket Following Overnight Announcement of Quarterly Dividend Cut Amid Lexmark Acquisition-February 2024-www.financetom.com

--Xerox Shares Slump Premarket Following Overnight Announcement of Quarterly Dividend Cut Amid Lexmark Acquisition

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Xerox Shares Slump Premarket Following Overnight Announcement of Quarterly Dividend Cut Amid Lexmark Acquisition

May 26, 2025 1:09 PM

04:56 AM EDT, 05/23/2025 (MT Newswires) --

Price: 4.67, Change: -0.45, Percent Change: -8.79

Previous page： Commerzbank on Overnight News Next page： Tesla launches free trial of assisted driving service in China

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Commerzbank on Overnight News

Mar 17, 2025

06:28 AM EDT, 03/17/2025 (MT Newswires) -- Commerzbank in its European Sunrise note of Monday highlighted: Markets: United States Treasuries recovered into New York close, are on the backfoot again in Asia. Asian stocks recover, e-minis consolidate. EUR rangebound around $1.088. Brent rises above $71/barrel. U.S.: President Donald Trump signs government funding bill after senate approval. NY Fed GDP Nowcast...

Tesla launches free trial of assisted driving service in China

Mar 17, 2025

BEIJING (Reuters) - Tesla is launching a free trial of its Full Self-Driving service in China from March 17 to April 16, the company said on its Chinese website. ...

Mar 17, 2025

...

AstraZeneca Strikes up to $1 Billion Deal to Buy EsoBiotec

Mar 17, 2025

06:26 AM EDT, 03/17/2025 (MT Newswires) -- AstraZeneca ( AZN ) on Monday agreed to acquire Belgian biotechnology company EsoBiotec in a deal worth up to $1 billion as it looks to boost its cell therapies portfolio. The UK drugmaker will acquire all of EsoBiotec's outstanding equity on a cash and debt-free basis, the companies said in separate statements. AstraZeneca...